The estimated Net Worth of Capital Management, Llc Kol... is at least 45.9 百万$ dollars as of 24 January 2019. Capital Kol owns over 263,158 units of Wave Life Sciences stock worth over 45,873,721$ and over the last 9 years Capital sold WVE stock worth over 0$.
Capital has made over 6 trades of the Wave Life Sciences stock since 2015, according to the Form 4 filled with the SEC. Most recently Capital bought 263,158 units of WVE stock worth 10,000,004$ on 24 January 2019.
The largest trade Capital's ever made was buying 2,237,130 units of Wave Life Sciences stock on 7 October 2015 worth over 24,295,232$. On average, Capital trades about 427,944 units every 134 days since 2015. As of 24 January 2019 Capital still owns at least 7,775,207 units of Wave Life Sciences stock.
You can see the complete history of Capital Kol stock trades at the bottom of the page.
Capital's mailing address filed with the SEC is 20 PARK PLAZA, SUITE 120020 PARK PLAZA, SUITE 1200, , BOSTONBOSTON, MAMA, 0211602116.
Over the last 9 years, insiders at Wave Life Sciences have traded over 19,158,839$ worth of Wave Life Sciences stock and bought 18,619,108 units worth 128,204,225$ . The most active insiders traders include Plc Gsk、Capital Management, L.P.Ra ...、Capital Management, Llc Kol.... On average, Wave Life Sciences executives and independent directors trade stock every 43 days with the average trade being worth of 1,569,819$. The most recent stock trade was executed by Paul Bolno on 21 August 2024, trading 48,366 units of WVE stock currently worth 279,555$.
wave life sciences ltd. (nasdaq: wve) is utilizing its innovative and proprietary synthetic chemistry drug development platform to design, develop and commercialize stereopure nucleic acid therapeutics that precisely target the underlying cause of rare genetic diseases, delivering new treatment options for patients. given the unique versatility of its chemistry platform, wave’s pipeline spans multiple oligonucleotide modalities including antisense, exon-skipping and single-stranded rnai.
Wave Life Sciences executives and other stock owners filed with the SEC include: